In Silico

(Image: Getty/ipopba)

Medidata acquired by French software firm Dassault Systèmes for $5.8bn

By Melissa Fassbender

Dassault Systèmes is set to acquire Medidata in an all-cash transaction valued at $5.8bn – a deal which will combine the power of modeling and simulation with data science to “catalyze the next generation of patient-inclusive therapeutics,” says CEO.

How in silico trials are making personalized medicine a reality

How in silico trials are making personalized medicine a reality

By Melissa Fassbender

The biopharma industry is on the precipice of making personalized medicine a reality with access to massive amounts of data, computing power, and artificial intelligence to run in silico clinical trials, says GNS Healthcare CEO.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers